| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.4 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |